Synergy Asset Management LLC Buys Shares of 9,602 Intuitive Surgical, Inc. $ISRG

Synergy Asset Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, HoldingsChannel.com reports. The fund purchased 9,602 shares of the medical equipment provider’s stock, valued at approximately $5,438,000.

Other large investors have also made changes to their positions in the company. Riversedge Advisors LLC raised its position in Intuitive Surgical by 1.9% during the fourth quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after purchasing an additional 17 shares in the last quarter. Fiduciary Financial Group LLC lifted its stake in Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after purchasing an additional 19 shares during the last quarter. Prosperity Consulting Group LLC boosted its holdings in shares of Intuitive Surgical by 0.5% in the 3rd quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock valued at $1,804,000 after purchasing an additional 19 shares in the last quarter. Rossmore Private Capital increased its stake in shares of Intuitive Surgical by 2.0% in the 3rd quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares during the last quarter. Finally, Activest Wealth Management increased its stake in shares of Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after purchasing an additional 20 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.3%

NASDAQ ISRG opened at $468.55 on Friday. The company has a market cap of $166.40 billion, a price-to-earnings ratio of 59.39, a price-to-earnings-growth ratio of 3.63 and a beta of 1.66. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The business’s fifty day moving average is $496.15 and its 200 day moving average is $513.04.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.21 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 645 shares of Intuitive Surgical stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares in the company, valued at $782,321.13. This trade represents a 28.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $65,829.68. Following the sale, the vice president directly owned 660 shares in the company, valued at $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 32,943 shares of company stock valued at $17,279,568. 0.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. Raymond James Financial upped their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Barclays set a $712.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research report on Monday, January 26th. Piper Sandler reissued an “overweight” rating and issued a $620.00 target price (up from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. Argus reduced their price target on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating on the stock in a research note on Wednesday, February 4th. Finally, Citigroup raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a report on Wednesday, March 11th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $614.95.

Key Stories Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive is taking direct control of da Vinci and Ion distribution in Southern Europe to improve sales, service and system availability — a move that should support long‑term revenue and customer uptime in a strategic region. Intuitive Surgical Extends Southern Europe Reach As Stock Trades Below Targets
• Positive Sentiment: Wall Street and retail commentary remain constructive: several recent pieces label ISRG a top pure‑play robotics buy and say analyst recommendations are generally favorable, supporting investor conviction around market leadership and long runway. Is Intuitive Surgical Inc. (ISRG) the best pure-play robotics stock to buy now?
• Positive Sentiment: Former management highlights Intuitive’s competitive moat in clinician training and ecosystem lock‑in — an important qualitative advantage that supports recurring procedure volume and replacement/system upgrade demand. Intuitive Surgical stock moat lies in training, former exec says
• Neutral Sentiment: Underlying fundamentals remain solid: the company posted a revenue and EPS beat in the most recent quarter (strong procedure growth and high margins), but those results are already priced into a premium multiple, so impact on near‑term price is mixed.
• Negative Sentiment: Shares have been under pressure — trading below some analyst targets and showing YTD weakness — which can amplify downside on headline volatility or broader market risk‑off days. Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
• Negative Sentiment: High valuation (elevated P/E) means the stock is sensitive to execution misses, slower procedure adoption or tougher macro conditions — risks investors are currently re‑pricing into the stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.